Crossmark

Factors Influencing the Efficacy and Safety of Monoclonal Antibody Biologics in Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials

Crossref DOI link: https://doi.org/10.1007/s00408-025-00795-6

Published Online: 2025-03-14

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Yuxin https://orcid.org/0000-0001-5717-953X
Luo, Jinmei https://orcid.org/0000-0001-5519-6205
Huang, Rong https://orcid.org/0000-0001-9584-0501
Xiao, Yi https://orcid.org/0000-0001-5315-7771
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82370052)
License Information

Text and Data Mining valid from 2025-03-14

Version of Record valid from 2025-03-14
More Information

Article History

Received: 22 December 2024

Accepted: 25 February 2025

First Online: 14 March 2025

Declarations

:

: All authors report no conflict of interest.

: This is a systematic review and meta-analysis. No ethical approval is required.

Document is current

Any future updates will be listed below